MaureenD(Donnelly)PassaroMD

Endocrinology • Olney, MD

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Passaro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Passaro's full profile

Already have an account?

Office
2901 Olney Sandy Spring Rd
Olney, MD 20832
Phone+1 301-774-6655

Fax+1 301-774-5652
Is this information wrong?

Summary

Dr. Maureen Passaro is an endocrinologist in Olney, MD and is affiliated with MedStar Montgomery Medical Center. She received her medical degree from New York Medical College and has been in practice 27 years. She specializes in diabetes and lipid metabolism.

Education & Training

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1996
Stamford Hospital/Columbia University College of Physicians and SurgeonsResidency, Internal Medicine, 1990 - 1993
New York Medical CollegeClass of 1990

Certifications & Licensure

DC State Medical License 1996 - Present
MD State Medical License 1993 - 2025
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups.
Howard, B. V., Adams-Campbell, L., Allen, C., Black, H., Passaro, M., Rodabough, R. J., Rodriguez, B. L., Safford, M., Stevens, V. J., Wagenknecht, L. E.> ;Int J Obes Relat Metab Disord. 2004 Aug
67 citations
Development of the selective progesterone receptor modulator CDB-2914 for clinical indications.
Diana L. Blithe, Lynnette K. Nieman, Richard P. Blye, Pamela Stratton, Maureen D Passaro> ;Steroids. 2003 Nov 1
27 citations
Luteal phase dose–response relationships of the antiprogestin CDB‐2914 in normally cycling women*
Maureen D Passaro, Nancy Mullen, Dorette Sutherland, Suoping Zhai, William D Figg, Richard P. Blye, Lynnette K. Nieman> ;Human Reproduction. 2003 Sep 1
125 citations
Statin Use, Clinical Fracture, and Bone Density in Postmenopausal Women: Results from the Women's Health Initiative Observational Study
Andrea Z. LaCroix, Jane A. Cauley, Mary Pettinger, Judith Hsia, Douglas C. Bauer, Joan McGowan, Zhao Chen, Cora E. Lewis, S. Gene McNeeley, Maureen D. Passaro, Rebecca...> ;Annals of Internal Medicine. 2003 Jul 15
Combination oral agent and insulin therapy for type 2 diabetes mellitus.
Maureen D. Passaro, Robert E. Ratner> ;Current Diabetes Reports. 2001 Oct 1
81 citations
Effect of physician specialty on outcomes in diabetic ketoacidosis.
Claresa S. Levetan, Maureen D. Passaro, Kathleen A. Jablonski, Robert E. Ratner> ;Diabetes Care. 1999 Nov 1
Time length of negativization of hCG serum values after either surgical or medical treatment of ectopic pregnancy.
Colacurci N, De Franciscis P, Zarcone R, Fortunato N, Passaro M, Mollo A, Russo G> ;Panminerva Med. 1998-09-01
Bone density in women with endometriosis.
Colacurci, N., De Seta, L., Passaro, M., Scala, P., De Franciscis, P., Zarcone, R.> ;Panminerva Med. 1998 Jun
Effects of hormone replacement therapy on glucose metabolism.
Colacurci N, Zarcone R, Mollo A, Russo G, Passaro M, de Seta L, de Franciscis P> ;Panminerva Med. 1998-03-01
218 citations
Unrecognized Diabetes Among Hospitalized Patients
Claresa S. Levetan, Maureen D. Passaro, Kathleen A. Jablonski, Mary E. Kass, Robert E. Ratner> ;Diabetes Care. 1998 Feb 1
Factitious Cushing syndrome.
Cizza, G., Nieman, L. K., Doppman, J. L., Passaro, M. D., Czerwiec, F. S., Chrousos, G. P., Cutler, G. B.> ;J Clin Endocrinol Metab. 1996 Oct
Join now to see all